Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Marketing application filed in Australia for PhotoCure's Metvix PDT

March 16, 2001

Id4 identified as regulator of BRCA1 expression

March 16, 2001

Patient enrollment complete in pivotal phase III trial of Xcytrin

March 15, 2001

Morphochem/Sosei collaboration will optimize anticancer telomerase inhibitor

March 15, 2001

Cumulative neuromuscular toxicity is dose-limiting for LU-79553

March 15, 2001

OSI begins first in series of OSI-774 trials in combination with anticancer agents

March 15, 2001

NIH technology available for licensing: antiprogestins with partial agonist activity

March 15, 2001

Ceramide analogues from Bracco induce apoptosis in cancer cells

March 14, 2001

Second-generation Vitaxin enters phase I evaluation for treatment of solid tumors

March 14, 2001

TranXenoGen licenses novel anticancer protein

March 14, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...